LifeMD is trading 5.72% up at $3.51 in after-hours trading after its $3.32 close on August 17, 2026; catalyst unconfirmed.

  • Latest August 5 earnings: $47.3 million second-quarter revenue and approximately $3.5 million adjusted EBITDA loss.
  • S&P 500 down 0.50%; Nasdaq Composite down 0.27%, so market sentiment does not clearly explain the opposite-direction gain.
  • No company-specific announcement, earnings release, filing, or late-breaking catalyst was identified for August 17; the move may reflect trading activity or delayed reaction.